Pharmaceutical formulation enables the development of dosage forms that optimize API delivery, stability, bioavailability, and patient compliance.
At Microsphere, our expertise in formulation development, combined with advanced manufacturing capabilities, streamlines the scale-up process for even the most complex formulations, helping accelerate project timelines and speed up development.
Since each polymorph can exhibit distinct physical and chemical properties, controlling the solid state is crucial to optimizing product bioavailability and stability, while also strengthening intellectual property protection and patent strategies.
At Microsphere, advanced analytical tools such as XRPD, DSC, mDSC and DVS are available to support comprehensive solid-state characterization.
By evaluating crystallinity, solid phases stability, purity, excipient compatibility and late-appearing polymorph. These studies support the development of stable, efficient and high-quality pharmaceutical products.
Our Particle Engineering expertise, supported by innovative technologies, ensures that your drug substances meet critical quality attributes, bioavailability requirements, and formulation targets, driven by a robust solid state.
Why Particle Engineering matters in API Engineering:
